Diosmin
| Compound Structure: |
.png)
|
||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms: | Diosmin; Barosmin; Diosimin; Venosmine; Diosmil; Flebosten; Diosmine; Daflon; Tovene; Ven-Detrex; Diovenor; Buchu Resin; Litosmil; Veno-V; Flebosmil; Diosminum; Rioven | ||||||||||||||||||||||||||||||||||||||||||||
| Compound ID: | NMPC-971 | ||||||||||||||||||||||||||||||||||||||||||||
| PubChem ID: | |||||||||||||||||||||||||||||||||||||||||||||
| Molecular Formula: | C28H32O15 | ||||||||||||||||||||||||||||||||||||||||||||
| Canonical SMILES: | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O | ||||||||||||||||||||||||||||||||||||||||||||
| InChIKey: | GZSOSUNBTXMUFQ-YFAPSIMESA-N | ||||||||||||||||||||||||||||||||||||||||||||
| About the compound: | Diosmin is a disaccharide derivative that consists of diosmetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as an antioxidant and an anti-inflammatory agent. It is a glycosyloxyflavone, a rutinoside, a disaccharide derivative, a monomethoxyflavone and a dihydroxyflavanone. It is functionally related to a diosmetin. Chronic venous insufficiency is a common condition the western population. Compression and pharmacotherapy are frequently used to manage chronic venous insufficiency, improving circulation and symptoms of venous disease. Diosmin is a bioflavonoid isolated from various plants or synthesized from [hesperidin]. It is used for the improvement of capillary fragility or venous insufficiency, including chronic venous insufficiency (CVI) and hemorrhoids. Diosmin is widely available over-the-counter and demonstrates a favourable a favorable safety profile. GHS Hazard Statements Not Classified Reported as not meeting GHS hazard criteria by 89 of 98 companies (only ~ 9.2% companies provided GHS information). For more detailed information, please visit ECHA C&L website. |
||||||||||||||||||||||||||||||||||||||||||||
| Properties: |
Chemical
and Physical Properties Computed
Properties
Source: PubChem |
||||||||||||||||||||||||||||||||||||||||||||
| Source Species: |